1. |
Tentori F, Blayney MJ, Albert JM, et al. Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis, 2008, 52(3): 519-530.
|
2. |
Moe S, Drüeke T, Cunningham J, et al. Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int, 2006, 69(11): 1945-1953.
|
3. |
Floege J, Kim J, Ireland E, et al. Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population. Nephrol Dial Transplant, 2011, 26(6): 1948-1955.
|
4. |
Raggi P, Boulay A, Chasan-Taber S, et al. Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol, 2002, 39(4): 695-701.
|
5. |
de Alarcón RM, Palomares M, Marfil A, et al. Posttransplant regression of uremic tumoral calcinosis.Nefrologia, 2007, 27(3): 378-381.
|
6. |
Baek D, Lee SE, Kim WJ, et al. Greater trochanteric pain syndrome due to tumoral calcinosis in a patient with chronic kidney disease. Pain Physician, 2014, 17(6): E775-E782.
|
7. |
Xu Z, Tang C, Zhang L, et al. Multiple ectopic calcification in subcutaneous tissues detected by bone scintigraphy in a patient with chronic renal failure. Clin Nucl Med, 2015, 40(6): 512-514.
|
8. |
周建平, 李晓莉, 董明, 等. 我国原发性甲状腺功能亢进症的误诊情况分析. 中国现代医学杂志, 2006, 16(7): 1040-1042.
|
9. |
Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int, 2004, 66(6): 2293-2299.
|
10. |
Kapustin AN, Davies JD, Reynolds JL, et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circ Res, 2011, 109(1): e1-e12.
|
11. |
Sunder S, Verma H, Venkataramanan K. Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient. Hemodial Int, 2013, 17(3): 458-462.
|
12. |
曲建坤, 王兆新, 王焱. 甲状旁腺切除对继发性甲状旁腺功能亢进的维持性血透患者左心功能及生存质量的影响. 临床心血管病杂志, 2015, 31(10): 1078-1081.
|
13. |
Latif F, Khalid MM, Khan F, et al. Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review. J Cardiovasc Med (Hagerstown), 2013, 14(6): 410-415.
|
14. |
Binnani P, Aggarwal V, Bahadur MM, et al. Tumoral calcinosis (Teutschlander disease) in a dialysis patient. Indian J Nephrol, 2008, 18(3): 122-124.
|
15. |
廖常志, 张静, 何强. 等. 慢性肾脏病患者血清 iPTH 及钙磷异常的发生率. 四川医学, 2011, 32(9): 1338-1340.
|
16. |
Niemann KE, Kröpil F, Hoffmann MF, et al. A 23-year-old patient with secondary tumoral calcinosis: Regression after subtotal parathyroidectomy: A case report. Int J Surg Case Rep, 2016, 23: 56-60.
|